Biostar Pharma, Inc.
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases (NCT06764940) | Biostar Pharma, Inc. | 2025-07-14 |
| Tolerability of Utidelone Capsule in Patients With Advanced Solid Tumors (NCT05681000) | Biostar Pharma, Inc. | 2023-06-09 |
Track Biostar Pharma, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.